These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31705008)

  • 1. Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes.
    Tofte N; Suvitaival T; Ahonen L; Winther SA; Theilade S; Frimodt-Møller M; Ahluwalia TS; Rossing P
    Sci Rep; 2019 Nov; 9(1):16398. PubMed ID: 31705008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes.
    Pongrac Barlovic D; Harjutsalo V; Sandholm N; Forsblom C; Groop PH;
    Diabetologia; 2020 Sep; 63(9):1847-1856. PubMed ID: 32564139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
    Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
    Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
    Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus.
    Tougaard NH; Theilade S; Winther SA; Tofte N; Ahluwalia TS; Hansen TW; Rossing P; Frimodt-Møller M
    J Am Heart Assoc; 2020 Oct; 9(19):e017165. PubMed ID: 32955366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes.
    Limonte CP; Valo E; Montemayor D; Afshinnia F; Ahluwalia TS; Costacou T; Darshi M; Forsblom C; Hoofnagle AN; Groop PH; Miller RG; Orchard TJ; Pennathur S; Rossing P; Sandholm N; Snell-Bergeon JK; Ye H; Zhang J; Natarajan L; de Boer IH; Sharma K
    Am J Nephrol; 2020; 51(10):839-848. PubMed ID: 33053547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.
    Velho G; Bouby N; Hadjadj S; Matallah N; Mohammedi K; Fumeron F; Potier L; Bellili-Munoz N; Taveau C; Alhenc-Gelas F; Bankir L; Marre M; Roussel R
    Diabetes Care; 2013 Nov; 36(11):3639-45. PubMed ID: 23863910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin genotype and renal function decline in type 1 diabetes.
    Costacou T; Ferrell RE; Ellis D; Orchard TJ
    Diabetes; 2009 Dec; 58(12):2904-9. PubMed ID: 19720796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
    Ahola AJ; Sandholm N; Forsblom C; Harjutsalo V; Dahlström E; Groop PH;
    Kidney Int; 2017 May; 91(5):1178-1185. PubMed ID: 28238338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes.
    Ferreira-Divino LF; Suvitaival T; Rotbain Curovic V; Tofte N; Trošt K; Mattila IM; Theilade S; Winther SA; Hansen TW; Frimodt-Møller M; Legido-Quigley C; Rossing P
    Cardiovasc Diabetol; 2022 Jul; 21(1):135. PubMed ID: 35850688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.